Carrageenin hyperthermia in rats.
D000818:Animals; D001241:Aspirin / Q000627:therapeutic use; D001831:Body Temperature / Q000187:drug effects*; D002351:Carrageenan / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000139:chemically induced; D005260:Female; D005334:Fever / Q000139:chemically induced* / Q000378:metabolism / Q000517:prevention & control; D006614:Hindlimb; D007213:Indomethacin / Q000627:therapeutic use; D008954:Models, Biological; D010653:Phenylbutazone / Q000627:therapeutic use; D011453:Prostaglandins / Q000096:biosynthesis; D051381:Rats
D011453:Prostaglandins; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin